In Discovering New Treatments for Disease, Doctors Depend on the Best Equipment

the laboratory test tubes with colorful liquid

(DGIwire) – Success in treating disease largely depends on the availability and quality of medical tests and tools. At Australia’s Monash University, researchers have patented a quick, inexpensive test to detect early-stage malaria. Malaria is tough to diagnose because only small numbers of immature parasites are present in the bloodstream. Once they mature, the parasites hide away in the tissues. It is important to make an early diagnosis before the parasites lodge in brain capillaries, causing complications that can lead to death.

The procedure uses infrared light to locate fatty acids in the parasite—a marker for the disease. The light detects the vibrations of molecules, which in turn allows doctors to determine the age and number of parasites in the blood. The test provides results in minutes. According to its developers, the tool has the potential to dramatically reduce the number of people dying from malaria in remote communities.

Like the Australian researchers, medical device companies around the world are focused on helping alleviate human diseases, but by distributing efficient, cost-effective and cutting-edge life science research equipment worldwide. These tools enable scientists to make the advances that translate into tomorrow’s treatments and cures.

One of the most distinguished of these companies is Holliston, MA-based Harvard Bioscience, a global developer, manufacturer and marketer of a broad range of equipment, instruments and solutions to advance life science. Researchers in more than 100 countries use the company’s line of products. The company is committed to getting the latest equipment into laboratories in an effort to do well by doing good.

Harvard Bioscience began in 1901 at Harvard University when Dr. William T. Porter started manufacturing his own lab equipment after being dissatisfied with the poor quality of the ones the medical school provided for him. From there, Dr. Porter went on to found the American Journal of Physiology and to become one of the leading physiologists of his day. His tools quickly gained an enviable reputation for quality and reliability, and became the seed for what the company would eventually grow into.

Jeffrey A. Duchemin, President and CEO of Harvard Bioscience, says, “We are acutely aware that researchers depend on the quality and power of their instruments to innovate new treatments for patients. We are dedicated to providing the best-quality equipment in the hopes of facilitating this process as much as possible in labs around the world.”

Copyright-free content provided by DGIwire.

close